Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects Source: Eur Respir J, 56 (2) 2002378; 10.1183/13993003.02378-2020 Year: 2020
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 663s Year: 2006
Expression of versican in large and small airways and parenchyma in lungs of non-smokers, smokers and COPD patients Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009
Bronchial airway expression of mucin-related, ENaC and chloride channel genes in COPD and non-COPD smokers compared to former and never smokers Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD Source: Annual Congress 2010 - Cell biology and immunology of lung disease Year: 2010
Enhanced T cell growth from bronchial biopsies of COPD ex-smokers and severe asthmatic subjects compared to COPD current smokers Source: Eur Respir J 2004; 24: Suppl. 48, 39s Year: 2004
Pathology of small airways in non-COPD smokers with low diffusion capacity and patients with COPD Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020
Alterations of the soluble proteome of airway epithelial cells in COPD Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013
Increased expression of nuclear factor-κB in bronchial biopsies from smokers and patients with COPD Source: Eur Respir J 2002; 20: 556-563 Year: 2002
Expression and release of interleukin-8 by human bronchial epithelial cells from patients with chronic obstructive pulmonary disease, smokers and healthy controls Source: Eur Respir J 2001; 18: Suppl. 33, 520s Year: 2001
The clinical importance of small airway involvement in patients with asthma and COPD Source: International Congress 2019 – PG12 Recent advances in small airways diseases in patients with asthma and COPD Year: 2019
Different role of p21 in the remodelling of central and peripheral airway epithelium in smokers with and without COPD Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010
COPD bronchial brush microbiome association with lung function and bronchial gene expression Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020
The lower airways microbiome in patients with IPF and COPD Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019
Abnormal M1/M2 macrophage switching in small airway wall and lumen of smokers and COPD patients Source: International Congress 2017 – New insights into pathogenesis of lung disease Year: 2017
Expression of cholinergic system components in the airway epithelium of COPD patients Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008
Epithelial mesenchymal transition (EMT) related changes in small airways of smokers and patients with COPD Source: Virtual Congress 2021 – Pathogenic progress in airway diseases Year: 2021
Increased expression of SARS-CoV-2 (Covid-19) adhesion sites on type II pneumocytes, small airway epithelium, and alveolar macrophages in smokers and patients with COPD Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021
Decreased expression of TGFβ1 type II receptor in bronchial glands of smokers with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 98s Year: 2004
Increased circulating alveolar epithelial microparticles in COPD patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015